Teleflex (TFX) has quietly become a talking point after another choppy week for medtech names, with the stock drifting lower over the past week even as the past month’s performance turned positive.

We came across a bullish thesis on Teleflex Incorporated on Valueinvestorsclub.com by Sarelam34. In this article, we will summarize the bulls’ thesis on TFX. Teleflex Incorporated’s share was trading ...

Teleflex announced that it agreed to sell its Acute Care, Interventional Urology and OEM businesses for a combined $2.03 ...

Truist raised the firm’s price target on Teleflex (TFX) to $135 from $120 and keeps a Hold rating on the shares as part of a broader research note ...

Teleflex’s TFX Interventional Urology portfolio is well positioned for sustained growth, led by UroLift’s expanding global ...

Investors interested in stocks from the Medical - Instruments sector have probably already heard of Teleflex (TFX) and SONOVA HOLDING (SONVY). But which of these two stocks is more attractive to value ...

Medical device maker Teleflex said on Tuesday it would sell three units for a combined $2.03 billion, as it sharpens its ...

In recent trading, shares of Teleflex Incorporated (Symbol: TFX) have crossed above the average analyst 12-month target price of $125.50, changing hands for $131.25/share. When a stock reaches the ...

Teleflex stock (NYSE: TFX), best known for its single-use medical devices for common diagnostic and therapeutic procedures, has seen a 31% fall this year, underperforming the broader S&P500 index, ...